Search Results
Dr Sharon Cohen Featured in CNBC Report on Biogen's Aducanumab during PBS Business News Hour
Biogen to seek FDA approval for Alzheimer's drug Aducanumab
What Does an Alzheimer's Drug Relaunch Mean For A Cure? | Brain Talks | Being Patient
Cramer: Biogen's Alzheimer's treatment would be 'the biggest drug ever'
FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decades
Howard Fillit, MD: Aducanumab Findings Lead the Way in Dementia
New details emerge on drug that may slow Alzheimer’s disease
Toronto Memory Program Featured on CTV Toronto News at 6 — January 25, 2019
Sangamo and Biogen's Gene Regulation Therapy to Fight Alzheimer's
Jeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical Pipeline
Clinical Trial Participant 'Biogen's Aducanumab Was Working' | Patient Perspectives | Being Patient
The future of Alzheimer’s disease: aducanumab
